Autonomic Disorders Clinical Trials & Translational Studies
Studies led by investigators in the Division of Autonomic Disorders aim to advance our ability to effectively treat genetic disorders, synucleinopathies, and multiple system atrophy, among other conditions.
Genetic Disorders
Natural History of Familial Dysautonomia (FD)
Principal investigator: Horacio Kaufmann, MD
Natural History of Congenital Insensitivity to Pain with Anhidrosis (CIPA)
Principal investigator: Horacio Kaufmann, MD
Muscle Dysfunction in Familial Dysautonomia
Principal investigator: Horacio Kaufmann, MD
Generation of Disease Models with Induced Pluripotent Stem Cells (iPSCs) in Hereditary Sensory and Autonomic Neuropathies
Principal investigator: Alejandra Gonzalez-Duarte Briseno, MD
Synucleinopathies
Natural History Study of Synucleinopathies
Principal investigator: Horacio Kaufmann, MD
Synucleinopathy and Constipation
Principal investigator: Rita M. Knotts, MD
Multiple System Atrophy
Clinical Trial Readiness for Multiple System Atrophy (MSA)
Principal investigator: Horacio Kaufmann, MD
The Global Multiple System Atrophy Registry (GLoMSAR)
Principal Investigator: Horacio Kaufmann, MD
TRACK-MSA
Principal investigator: Horacio Kaufmann, MD
Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy (CYPRESS)
Principal Investigator: Patricio A. Millar Vernetti, MD
AMULET—Delay Multiple System Atrophy
Principal investigator: Patricio A. Millar Vernetti, MD
UB-312 in Patients With Synucleinopathies
Principal Investigator: Horacio Kaufmann
A Study of TAK-341 in Treatment of Multiple System Atrophy
Principal Investigator: Patricio A. Millar Vernetti, MD
Contact Us
To learn more about our clinical trials or to participate, please call Jose Martinez, senior clinical trials manager, at 212-263-7225.